(EMAILWIRE.COM, July 25, 2018 ) Cell-based assays cover a range of assays that measure cellular parameters akin to cell toxicity, proliferation, production of markers, activation of specific signal pathways, mobility, and changes in morphology. These assays have high sensitivity owing to signal amplification of cell-signaling cascades, and therefore are ideal for miniaturization. Cell-based assays are widely applied in high-throughput screening (HTS) formats.

View sample: https://www.marketdataforecast.com/market-reports/global-cell-based-assay-market-2218/request-sample

Cell-Based Assay Market was worth USD 12.98 billion in 2018 and estimated to be growing at a CAGR of 11.2%, to reach USD 22.07 billion by 2023. Prevalence of various chronic diseases, government support for the analysis and development activities, and enhancement of health care infrastructure in rising economies are some of the factors fueling the market growth.

To know more read: https://www.marketdataforecast.com/market-reports/global-cell-based-assay-market-2218/

Trends and Analysis
The demand for cell-based assay has increased considerably over the past few years, thanks to the surge in cell-based applications in drug discovery and rise in technological advancements in cell-based assays methodologies. Additionally, adoption of high-throughput screening strategies and increase in R&D investment is set to drive the market growth. However, high prices related to these assays is hampering the market growth. Moreover, the surge in adoption of label-free cell-based assays and untapped potential in developing countries supply vital opportunities to the market players. Product launch, collaboration & merger, and acquisition are the key ways adopted by market players.

Get your customized report: https://www.marketdataforecast.com/market-reports/global-cell-based-assay-market-2218/customize-report

Regional Overview:
North America generated the best revenue within the world cell-based assay market in 2016. However, Asia-Pacific possesses the market potential for growth of cell-based assays, owing to increase in awareness regarding these assays for drug discovery, the increase in cell-based assay applications, and others. This region is anticipated to expertise fast growth, in terms of development and use of cell-based assays.

The major market contributors for the global Cell Based Assay Market are Thermo Fisher Scientific Inc., Becton, Dickinson and Company, Merck & Co. Inc., Cell Signalling Technology Inc., PerkinElmer Inc., Danaher Corporation, General Electric Company, Cisbio Bioassays, DiscoveRx, Ametek Inc., Bio-Rad Laboratories, Roche Diagnostics, GE Healthcare and Promega Corporation.

About MarketDataForecast™
Market Data Forecast is a market research firm offering syndicated research, consults and industry newsletters across various domains & verticals. With a well-established in-house team of experts from diverse fields and outsource research network across 100+ countries, we are the sole research providers for the majority of Fortune 500 companies. Along with the standards of reports being on par excellence, our unique services like free customization, analyst support for the period of six months post to the purchase will be the flag bearers and differentiates us from the rest. Our experience and in-depth understanding of various business environments will be a support to you and your organization in making well-informed decisions

Contact Info:
Name: Mr. Abhishek Shukla
Email: abhishek@marketdataforecast.com
Organization: MarketDataForecast™
Address: 2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
Phone: +1-888-702-9626

Contact Information:
Market Data Forecast.
Abhishek Shukla
Tel: +1-888-702-9626
Email us


----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results